tirzepatide discontinued FDA says shortage is over after taking a second look This dual Why Is Tirzepatide Not Working

This new medication works by going after the glucagon receptor

A phase IIb study of the efficacy and safety of tirzepatide in NASH patients is ongoing (SYNERGY-NASH, NCT04166773)

This is the question most Boulder patients come in with, and there is no universal answer

But if you show a flat response to tirzepatide as well, that is worth a direct conversation with your provider about whether GLP-1 therapy is the right primary approach for you

Lipopolysaccharide binds pattern-recognition receptors such as TLR4, triggers innate immune signaling, and releases inflammatory mediators including TNF-alpha

Booth A, Magnuson A, Fouts J, Foster M (2015) Adipose tissue, obesity and adipokines: role in cancer promotion